임상시험 트래커

Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral Anticoagulation

리드: 노바티스

Study to Assess Safety and Clinical Responses With Coartem® Baby Dispersible Tablets in Paediatric Patients Weighing 2 to <5 kg With Uncomplicated Malaria

리드: 노바티스

A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MS

협력: 노바티스

A Study of Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids.

리드: 노바티스

Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.

리드: 노바티스

Investigation of a Remibrutinib- and Omalizumab-based Treatment Algorithm in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Within 24 Weeks

리드: 노바티스

Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria

협력: 노바티스

Overcoming Racial Disparities in Screening Mammography

협력: 노바티스

A Study of the Safety and Effectiveness of Onasemnogene Abeparvovec (Zolgensma) Intrathecal Injection in Spinal Muscular Atrophy Patients

리드: 노바티스

A Real-world Study of Patients With Hidradenitis Suppurativa and High Cardiovascular Risk or Established Coronary Plaque Treated With Secukinumab

리드: 노바티스

A 52-Week Study Evaluating the Efficacy and Safety of Arumakimig (MAS825) in Participants With VEXAS Followed by Open-Label Extension (OLE) Period

리드: 노바티스

A Study of Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa Patients

리드: 노바티스

Pluvicto Real-world Investigation in Survival in Metastatic CRPC

리드: 노바티스

A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis

리드: 노바티스

A Real-World Study of Second-line Therapies Among Radioiodine-refractory Differentiated Thyroid Cancer (RAI-R DTC) Patients

리드: 노바티스

A Study to Evaluate Efficacy, Safety, and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)

리드: 노바티스

A Study of Clinical Practice and Real-world Care of Patients Treated With mTOR, PI3K, and MEK Inhibitors for Extracranial Vascular Anomalies

리드: 노바티스

A Study to Assess the Safety of Subcutaneous Secukinumab for Treatment in Adult Indian Participants With Axial Spondyloarthritis (axSpA), Ankylosing Spondylitis (AS), and Non-Radiographic Axial Spondyloarthritis (nr-axSpA)

리드: 노바티스

A Study of Asciminib Safety and Efficacy in Young Adults With Chronic Myeloid Leukemia in the Gulf Region

리드: 노바티스

Mechanistic Evaluation of Atrasentan in Patients With IgA Nephropathy (IgAN)

협력: 노바티스

A Study of Complement 3 Glomerulopathy (C3G) Patients Treated With Iptacopan Through an Early Access Program in Spain

리드: 노바티스

Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP

리드: 노바티스

A Real-world Study of the Effectiveness of Angiotensin Receptor-Neprilysin Inhibitor Therapy in Hypertensive Patients in the United Arab Emirates

리드: 노바티스

A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus

리드: 노바티스

A Study of [68Ga]Ga-DWJ155 in Adult Patients With Solid Tumors

리드: 노바티스

A Drug-drug Interaction Study to Assess the Effect of Phenytoin and Itraconazole on the Pharmacokinetics of Pelabresib in Healthy Participants

리드: 노바티스

Early Intensive Lipid-Lowering With Inclisiran for Plaque Stabilization in Acute Coronary Syndrome

협력: 한미약품, 노바티스

CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)

협력: 노바티스

A Study to Investigate the Pharmacokinetics and Safety of PKN605 in Participants With Moderate and Severe Renal Impairment Compared to Matched Control Subjects With Normal Renal Function

리드: 노바티스

Electronic Letters to Improve Patient Activation in IHD: The NUDGE-IHD Trial

협력: 노바티스

Lymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell Lymphoma

협력: 노바티스

Lp(a) Lowering Study of Pelacarsen (TQJ230) in Patients in the US With Elevated Lp(a) and Recent ACS (STEMI/NSTEMI) - Lp(a)FRONTIERS PEARL

리드: 노바티스

A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait

리드: 노바티스

ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)

리드: 노바티스

A 52-week Study of Remibrutinib in IgE-mediated Food Allergy

리드: 노바티스

A Real-World Medical Chart Review of Spinal Muscular Atrophy Patients Treated With Onasemnogene Abeparvovec in Saudi Arabia

리드: 노바티스

A Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)

리드: 노바티스

A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

리드: 노바티스

PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT

협력: 노바티스

Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.

협력: 노바티스

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

리드: 노바티스

A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.

리드: 노바티스

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

리드: 노바티스

Remibrutinib in Real-world Clinical Practice - a Germany Sub-study (REASSERT)

리드: 노바티스

PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan

리드: 노바티스

A Real-World Study of Ofatumumab in Multiple Sclerosis Patients in Germany and Japan

리드: 노바티스

A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea (PPR)

리드: 노바티스

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

리드: 노바티스

An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

리드: 노바티스

A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD

리드: 노바티스

Asciminib in HER2+ Breast Cancer Brain Metastases

협력: 노바티스

Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

리드: 노바티스

HJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With Hypertension

리드: 노바티스

Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi Arabia

리드: 노바티스

A Study of Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer

리드: 노바티스

177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer

협력: 노바티스

A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide Tetraxetan

리드: 노바티스

A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers

리드: 노바티스

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

리드: 노바티스

A Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With Eltrombopag

리드: 노바티스